| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 34,129 | 37,306 | 30,840 | 41,707 | | Cost of Revenue | 16,184 | 16,904 | 14,084 | 18,972 | | | Gross Profit | 17,945 | 20,402 | 16,756 | 22,735 | | | Operating Expenses | | Research Development | 745 | 576 | 619 | 627 | | Selling General and Administrative | 16,754 | 17,636 | 18,166 | 18,987 | | Non Recurring | 252 | 737 | 60 | 6,251 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 194 | 1,453 | (2,089) | (3,130) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 726 | 179 | (335) | (53) | | Earnings Before Interest And Taxes | 920 | 1,632 | (2,424) | (3,183) | | Interest Expense | 318 | 362 | 256 | 117 | | Income Before Tax | 602 | 1,270 | (2,680) | (3,300) | | Income Tax Expense | (324) | 635 | (1,731) | 441 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 926 | 635 | (949) | (3,741) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 926 | 635 | (949) | (3,741) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $926 | $635 | ($949) | ($3,741) |
|
0.51% Nasdaq 
Income Statement
